MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-02-2026
Regional Health Properties Cost of Revenue 2011-2026 | RHE
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Regional Health Properties
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.98 M | 6.98 M | 6.98 M |
Quarterly Cost of Revenue Regional Health Properties
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22 M | 19.1 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22 M | 2.47 M | 14.5 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B |  USA |
 |
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 22.48 | 0.31 % | $ 7.05 B |  Germany |
 |
Avalon GloboCare Corp.
AVCO
|
1.1 M | - | 26.45 % | $ 70.6 M | USA |
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M |  China |
 |
Chemed Corporation
CHE
|
1.58 B | $ 386.36 | 1.51 % | $ 5.8 B | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 3.91 | - | $ 512 M | China |
 |
Acadia Healthcare Company
ACHC
|
1.69 B | $ 24.91 | 3.96 % | $ 2.28 B | USA |
 |
AMN Healthcare Services
AMN
|
2.54 B | $ 18.56 | 1.98 % | $ 727 M | USA |
 |
American Shared Hospital Services
AMS
|
23 M | $ 1.34 | -0.74 % | $ 8.87 M | USA |
 |
Community Health Systems
CYH
|
1.86 B | $ 2.97 | 0.34 % | $ 397 M | USA |
 |
Encompass Health Corporation
EHC
|
3.12 B | $ 105.15 | 7.97 % | $ 10.6 B | USA |
 |
The Ensign Group
ENSG
|
4.02 B | $ 197.98 | 0.69 % | $ 11.3 B | USA |
 |
HCA Healthcare
HCA
|
32.9 B | $ 483.92 | 2.56 % | $ 114 B | USA |
 |
Healthcare Services Group
HCSG
|
1.6 B | $ 18.79 | 2.4 % | $ 1.36 B | USA |
 |
Hanger
HNGR
|
398 M | - | - | $ 732 M | USA |
 |
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | USA |
 |
The Joint Corp.
JYNT
|
9.17 M | $ 8.85 | 2.91 % | $ 128 M | USA |
 |
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | USA |
 |
MEDNAX
MD
|
1.54 B | $ 21.69 | 2.41 % | $ 1.82 B | USA |
 |
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | USA |
 |
National HealthCare Corporation
NHC
|
921 M | $ 164.13 | 0.85 % | $ 2.54 B | USA |
|
Novo Integrated Sciences
NVOS
|
7.55 M | - | -13.87 % | $ 1.52 M | USA |
 |
Option Care Health
OPCH
|
4.56 B | $ 27.73 | 0.95 % | $ 4.5 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
896 M | $ 54.94 | -1.04 % | $ 2.23 B | USA |
 |
The Pennant Group
PNTG
|
769 M | $ 29.92 | 0.88 % | $ 1.03 B | USA |
 |
Select Medical Holdings Corporation
SEM
|
4.82 B | $ 16.38 | 0.18 % | $ 2.01 B | USA |
 |
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | USA |
 |
Surgery Partners
SGRY
|
971 M | $ 12.3 | 0.99 % | $ 1.56 B | USA |
|
Sanara MedTech
SMTI
|
7.52 M | $ 17.19 | -0.29 % | $ 148 M | USA |
 |
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | USA |
 |
Tenet Healthcare Corporation
THC
|
8.7 B | $ 190.28 | 1.12 % | $ 17.2 B | USA |
 |
Universal Health Services
UHS
|
8.08 B | $ 181.33 | 2.62 % | $ 11.5 B | USA |
 |
U.S. Physical Therapy
USPH
|
462 M | $ 74.04 | 0.41 % | $ 1.12 B | USA |
 |
Ontrak
OTRK
|
4.02 M | - | -11.98 % | $ 1.53 M | USA |
 |
Addus HomeCare Corporation
ADUS
|
961 M | $ 93.5 | 2.09 % | $ 1.69 B | USA |
 |
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
2.12 B | $ 22.82 | -1.13 % | $ 11.3 B | USA |